批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2019/06/19 |
SUPPL-29(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/07/02 |
SUPPL-24(补充) |
Approval |
Labeling |
STANDARD
;Orphan
|
|
|
2013/04/13 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/02/22 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/05/22 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/05/22 |
SUPPL-20(补充) |
Approval |
REMS |
N/A
|
|
|
2011/04/14 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/06/15 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/01/22 |
SUPPL-15(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2009/12/23 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2009/11/20 |
SUPPL-14(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2008/11/14 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/10/03 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/08/12 |
ORIG-1(原始申请) |
Approval |
Type 5 - New Formulation or New Manufacturer |
STANDARD
;Orphan
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:QUININE SULFATE 剂型/给药途径:CAPSULE;ORAL 规格:324MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021799 |
001 |
NDA |
QUALAQUIN |
QUININE SULFATE |
CAPSULE;ORAL |
324MG |
Discontinued |
Yes |
No |
AB |
2005/08/12
|
SUN PHARM INDUSTRIES |
091661 |
001 |
ANDA |
QUININE SULFATE |
QUININE SULFATE |
CAPSULE;ORAL |
324MG |
Prescription |
No |
No |
AB |
2012/09/28
|
TEVA PHARMS |
203112 |
001 |
ANDA |
QUININE SULFATE |
QUININE SULFATE |
CAPSULE;ORAL |
324MG |
Prescription |
No |
No |
AB |
2015/04/24
|
LUPIN LTD |
203729 |
001 |
ANDA |
QUININE SULFATE |
QUININE SULFATE |
CAPSULE;ORAL |
324MG |
Prescription |
No |
No |
AB |
2015/07/15
|
AMNEAL PHARMS |
204372 |
001 |
ANDA |
QUININE SULFATE |
QUININE SULFATE |
CAPSULE;ORAL |
324MG |
Prescription |
No |
Yes |
AB |
2015/07/22
|
NOVAST LABS |